Atlas Trials

Juvenile Absence Epilepsy

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Juvenile Absence Epilepsy

RecordFirmDate
A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy (NCT05109234)UCB Biopharma SRL2022-03-30
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy (NCT04666610)UCB Biopharma SRL2021-07-29
Flunarizine for Treatment Resistant Absence Epilepsy (NCT06153186)University of British Columbia2019-09-20

Track Juvenile Absence Epilepsy automatically

Every clearance here is in the API, with alerts when new ones post.